Can PT-141 cause joint pain?

This site's PT-141 studies do not report joint pain as a measured result. The two RECONNECT studies, in 1,267 women who had not reached menopause, over 24 weeks, found a modest rise in desire scores. They listed nausea, flushing, and headache, each in 10% or more. A 52-week follow-on in 684 women, where everyone knew they were getting the drug, gave long-term safety data for the approval. The result listed on this site does not include joint pain. Having no counted rate does not prove nobody's joints hurt. It proves that this FAQ cannot publish one.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of names, absences, and legal limits. Brand versus molecule, side effects this site's citations did not measure, how long the trials actually ran, what national legal-status fields can say, and why two-compound answers do not scale to a larger stack.